Cargando…
Disease- and Medication-Specific Differences of the Microbial Spectrum in Perianal Fistulizing Crohn’s Disease—Relevant Aspects for Antibiotic Therapy
Perianal fistulizing Crohn’s Disease (CD) with abscess formation represents an aggressive phenotype in Inflammatory Bowel Disease (IBD) with increased morbidity. Treatment is multidisciplinary and includes antibiotics, but knowledge about the microbial spectrum is rare often resulting in inadequate...
Autores principales: | Kelm, Matthias, Kusan, Simon, Surat, Güzin, Anger, Friedrich, Reibetanz, Joachim, Germer, Christoph-Thomas, Schlegel, Nicolas, Flemming, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687552/ https://www.ncbi.nlm.nih.gov/pubmed/36359202 http://dx.doi.org/10.3390/biomedicines10112682 |
Ejemplares similares
-
Microbial Spectrum and Antibiotic Resistance in Patients Suffering from Penetrating Crohn’s Disease
por: Kusan, Simon, et al.
Publicado: (2022) -
Early Ileocecal Resection Is an Effective Therapy in Isolated Crohn’s Disease
por: Kelm, Matthias, et al.
Publicado: (2021) -
Adenocarcinoma Arising from Perianal Fistulizing Crohn's Disease
por: Fornaro, Rosario, et al.
Publicado: (2018) -
Therapeutic Drug Monitoring in Perianal Fistulizing Crohn’s Disease
por: Zulqarnain, Mir, et al.
Publicado: (2022) -
Optimized timing of using infliximab in perianal fistulizing Crohn's disease
por: Sun, Xue-Liang, et al.
Publicado: (2020)